Some of the most notable ones include: Effective Weight Loss Many weight loss solutions are disappointing, but Lipo-B injections work every time
Food and Drug Administration (FDA) has now approved two oral GLP-1 drugs: an oral version of Novo Nordisks Wegovy at the end of 2025, and Eli Lillys daily, non-peptide pillorforglipron, a distinct competitor to oral semaglutide and different from Eli Lillys injectable tirzepatidecalled Foundayo in April, which is notable because it can be taken without restrictions on timing or food or water intake
Pedialite is the miracle hangover helper
Like Victoza, Saxenda is a once-daily injection but Saxenda dosage goes up to 3 mg daily , whereas Victoza is only prescribed up to 1.8 mg daily
A reported 50% of users taking the GLP-1 medications experience nausea
Higher levels of the glycoprotein promote fibrin formation, increasing a persons clot risk